79% upside: The 'frustrating' ASX share waiting to take off

Sometimes the market just hasn't yet woken up to the actual performance or potential of a business.

| More on:
A kid wearing a pilot helmet holds a paper plane up to the sky.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The efficient market hypothesis says share prices always reflect all available information about the businesses.

However, veteran ASX investors would know that in reality that's not necessarily true.

Sometimes the market just fails to fully appreciate the merits or the cons of a company and the stock becomes under- or overpriced.

Shrewd investors can take advantage of this "inefficiency", assuming that eventually the rest of the market wakes up and the stock price will "catch up".

'A lot more value' in business than the current valuation

One such candidate is diagnostic imaging provider ​​Capitol Health Ltd (ASX: CAJ).

The share price has fallen almost 17% over the past 12 months, and is actually trading at 21% below what it was in the middle of 2018.

However, Sequoia Wealth senior wealth manager Peter Day noted last month that Capitol Health reported pleasing results.

"First half 2023 revenue of $98.1 million was up 3.4% on the prior corresponding period," said Day.

"In the near term, we forecast a recovery in face-to-face general practitioner consultations as a catalyst for improving imaging volumes."

Shaw and Partners portfolio manager James Gerrish acknowledged that life as a Capitol Health investor hasn't been easy.

"I know Capitol Health has been a frustrating position," he said on a Market Matters Q&A.

"However, we do think there is a lot more value in their business than is being ascribed by the market, something more like 45, 50 cents."

Compared to the Tuesday trading price of 28 cents, a rise to 50 cents would represent a whopping 78.5% upside.

"For that reason, we are remaining patient — pardon the pun!"

The stock pays out a dividend yield of 3.64%, which could soothe the pain while you wait for the share price to climb.

Day also thinks the stock is a prudent buy.

"We believe Capitol Health is well positioned relative to peers given strong specialist recruitment and exposure to recovery locations in Victoria."

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why the Mesoblast share price is diving 18% after an FDA win

Investors are sending the Mesoblast share price tumbling on Friday. But why?

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Mesoblast share price rockets 30% on big US FDA news

Big news is giving this biotech a huge lift on Thursday.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Guess which ASX healthcare stock is jumping 12% on Wednesday

This shares is rocketing this morning. But why? Let's find out.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Healthcare Shares

Here is the dividend forecast to 2029 for CSL shares

Can this blue-chip giant provide healthy dividend income?

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

The best ASX 200 healthcare stocks to buy in 2025

These shares could give your portfolio a healthy boost next year according to Bell Potter.

Read more »

In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
Healthcare Shares

ASX 300 healthcare stock lifts off on promising new results

Up 28% in a year, the ASX healthcare stock is leaping higher on Thursday.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

If you'd invested $5,000 in this ASX 300 healthcare stock a year ago, you'd now have $30,000!

This stock has made millions for investors over just a few months.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

Has the Pro Medicus share price risen too high too quickly?

Pro Medicus shares have rocketed 173% since this time last year.

Read more »